Header cover image

Canadian (TSX) Clinical Research and Equipment Industry Analysis

UpdatedApr 15, 2024
DataAggregated Company Financials
Companies3
  • 7D-3.5%
  • 3M47.1%
  • 1Y119.8%
  • YTDn/a

In the last week, the Clinical Research and Equipment industry is up 7.4%, with Sona Nanotech up 6.8%. During this same period, the Rapid Dose Therapeutics underperformed, falling 9.1%. This means that the industry has gained 154% over the past year.

Industry Valuation and Performance

Has the Canadian Clinical Research and Equipment Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Mon, 15 Apr 2024CA$65.5mCA$4.9m-CA$3,306,237.00n/a-19.8x13.4x
Wed, 13 Mar 2024CA$76.6mCA$4.9m-CA$2,943,594.00n/a-26x15.6x
Fri, 09 Feb 2024CA$51.7mCA$4.9m-CA$1,290,813.00n/a-40.1x10.5x
Sun, 07 Jan 2024CA$209.1mCA$23.4m-CA$24,636,048.00n/a-8.5x8.9x
Tue, 05 Dec 2023CA$194.1mCA$23.5m-CA$24,854,730.00n/a-7.8x8.3x
Thu, 02 Nov 2023CA$193.7mCA$23.7m-CA$24,695,492.00n/a-7.8x8.2x
Sat, 30 Sep 2023CA$197.3mCA$23.7m-CA$24,695,492.00n/a-8x8.3x
Mon, 28 Aug 2023CA$199.0mCA$23.7m-CA$24,644,997.00n/a-8.1x8.4x
Wed, 26 Jul 2023CA$203.5mCA$23.5m-CA$24,780,404.00n/a-8.2x8.7x
Fri, 23 Jun 2023CA$175.6mCA$22.5m-CA$25,042,100.00n/a-7x7.8x
Sun, 21 May 2023CA$176.3mCA$22.5m-CA$24,991,382.00n/a-7.1x7.8x
Tue, 18 Apr 2023CA$187.1mCA$23.0m-CA$29,977,765.0039x-6.2x8.2x
Thu, 16 Mar 2023CA$187.5mCA$23.0m-CA$29,977,765.0035.1x-6.3x8.2x
Sat, 11 Feb 2023CA$193.7mCA$23.0m-CA$29,977,765.0040.3x-6.5x8.4x
Mon, 09 Jan 2023CA$190.2mCA$22.4m-CA$30,499,829.0035.1x-6.2x8.5x
Wed, 07 Dec 2022CA$192.7mCA$21.8m-CA$30,309,915.0039.1x-6.4x8.8x
Fri, 04 Nov 2022CA$189.9mCA$21.7m-CA$30,373,079.0067.6x-6.3x8.7x
Sun, 02 Oct 2022CA$165.4mCA$21.7m-CA$30,373,079.0087.8x-5.4x7.6x
Tue, 30 Aug 2022CA$216.1mCA$21.6m-CA$24,222,079.0081.1x-8.9x10x
Thu, 28 Jul 2022CA$169.3mCA$21.5m-CA$26,689,749.0020.5x-6.3x7.9x
Sat, 25 Jun 2022CA$164.0mCA$21.5m-CA$26,689,749.0020.5x-6.1x7.6x
Mon, 23 May 2022CA$202.6mCA$21.5m-CA$26,635,227.0015.9x-7.6x9.4x
Wed, 20 Apr 2022CA$231.0mCA$21.6m-CA$23,635,914.0027.3x-9.8x10.7x
Fri, 18 Mar 2022CA$167.3mCA$21.6m-CA$23,635,914.0026.6x-7.1x7.8x
Sun, 13 Feb 2022CA$200.3mCA$21.3m-CA$21,103,914.0026.6x-9.5x9.4x
Tue, 11 Jan 2022CA$245.3mCA$20.9m-CA$20,076,847.0028.6x-12.2x11.7x
Thu, 09 Dec 2021CA$255.4mCA$21.0m-CA$14,997,109.0025.9x-17x12.2x
Sat, 06 Nov 2021CA$258.9mCA$21.0m-CA$14,997,109.0024.6x-17.3x12.3x
Mon, 04 Oct 2021CA$227.5mCA$20.7m-CA$14,899,797.0023.9x-15.3x11x
Wed, 01 Sep 2021CA$252.8mCA$20.7m-CA$11,409,216.0023.2x-22.2x12.2x
Thu, 08 Jul 2021CA$217.1mCA$19.8m-CA$8,728,216.0022.5x-24.9x11x
Price to Earnings Ratio

-33.7x


Total Market Cap: CA$239.1mTotal Earnings: -CA$7,096,150.00Total Revenue: CA$19.3mTotal Market Cap vs Earnings and Revenue0%0%0%
Canadian Clinical Research and Equipment Industry Price to Earnings3Y Average -12.1x202220232024
Current Industry PE
    There are only 3 companies in the Canadian Life Sciences Tools and Services industry, so there is insufficient data to make an industry-wide assessment of both the PE and PS ratio.
Past Earnings Growth
  • The earnings for companies in the Life Sciences Tools and Services industry have improved over the last three years.
  • Meanwhile revenues for these companies have declined 37% per year.
  • This means that less sales are being generated overall, but since the cost of doing business is lower, losses have been shrinking.

Industry Comparison

How does Canadian Clinical Research and Equipment compare with similar industries?

CA Market-1.51%
Healthcare-6.10%
Life Sciences-3.53%
Clinical Research and Equipment-3.53%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
TELI Telescope InnovationsCA$0.365.9%
+CA$1.1m
100.0%PS5.1x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.

Latest News

SONA

CA$0.41

Sona Nanotech

7D

-7.8%

1Y

130.6%

DOSE

CA$0.21

Rapid Dose Therapeutics

7D

-4.5%

1Y

n/a

TELI

CA$0.36

Telescope Innovations

7D

5.9%

1Y

100.0%